Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
|
|
New York Times (12.22.02) - Monday, December 23, 2002
David Gonzalez
In awarding Haiti $25 million, international officials called the treatments and methods devised at the Gheskio Centers, which Pape directs, and other clinics a model for how poor countries with few resources can combat AIDS, and the tuberculosis and diarrhea that often attack people with the disease.
Gheskio has had impressive results fighting severe diarrhea with antibiotics, has developed methods of diagnosing STDs and has found some less expensive drug combinations to treat AIDS. It and other private groups use funds provided by foundations and foreign governments to buy the medicines, which are priced far beyond the reach of most Haitians. The Global Fund grant will provide medication for about 1,200 more people.
The UN Development Program and the Sogebank Foundation, the philanthropic branch of Haiti's leading bank, will manage the funds, which are expected to arrive this month and to be used over a two-year period. Anil Soni, adviser to the fund's executive director, said the arrangement aimed to maximize efficiency and nurture cooperation between the public and private sectors. If it works, the fund could eventually provide Haiti as much as $67 million over five years, Soni said.
Pape's group now plans to train staff from government clinics as part of his project's activities financed by the Fund. He is confident that with enough resources, the country can hold the line on the disease until a vaccine is discovered.
021223
AD022479
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.